
Tetrabenazine Racemate
CAS No. 718635-93-9
Tetrabenazine Racemate( Ro 1-9569 Racemate )
Catalog No. M19033 CAS No. 718635-93-9
Tetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 41 | In Stock |
![]() ![]() |
25MG | 75 | In Stock |
![]() ![]() |
50MG | 112 | In Stock |
![]() ![]() |
100MG | 149 | In Stock |
![]() ![]() |
200MG | 194 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTetrabenazine Racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).
-
DescriptionTetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2). Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high-affinity label for the vesicle transport system.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 1-9569 Racemate
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorVMAT-2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number718635-93-9
-
Formula Weight317.43
-
Molecular FormulaC19H27NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 3.2 mg/mL; 10.08 mM
-
SMILESCC(C)CC1CN2CCc3cc(c(cc3C2CC1=O)OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jankovic, J. and J. Beach, Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology, 1997. 48(2): p. 358-62.
molnova catalog



related products
-
Perospirone hydrochl...
Perospirone hydrochloride is an atypical antipsychotic agent for the treatment of schizophrenia. ?It also displays affinity towards 5HT1A receptors as a partial agonist.
-
Cerlapirdine
Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
-
Olopatadine hydrochl...
Olopatadine hydrochloride is a histamine blocker used to treat allergic conjunctivitis.